Insulin receptor expression and activity in the brains of nondiabetic sporadic Alzheimer's disease cases

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Ho, Lap ^a   Yemul, Shrishailam ^a   Knable, Lindsay ^a   Katsel, Pavel ^a,b   Zhao, Rudy ^a   Haroutunian, Vahram ^a,b   Pasinetti, Giulio Maria ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; TAU PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CADAVER; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME REGULATION; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOUSE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TEMPORALIS MUSCLE;

EID: 84862272293     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/321280     Document Type: Article

References (59)

1. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L. A., Nilsson L., Persson G., Odén A., Svanborg A., 15-year longitudinal study of blood pressure and dementia The Lancet 1996 347 9009 1141 1145 (Pubitemid 126512042)
2. Leibson C. L., Rocca W. A., Hanson V. A., Cha R., Kokmen E., O'Brien P. C., Palumbo P. J., Risk of dementia among persons with diabetes mellitus: a population- based cohort study American Journal of Epidemiology 1997 145 4 301 308 (Pubitemid 27082028)
3. Stolk R. P., Breteler M. M. B., Ott A., Pols H. A. P., Lamberts S. W. J., Grobbee D. E., Hofman A., Insulin and cognitive function in an elderly population the rotterdam study Diabetes Care 1997 20 5 792 795 (Pubitemid 27202530)
4. Kilander L., Nyman H., Boberg M., Hansson L., Lithell H., Hypertension is related to cognitive impairment: a 20-year follow-up of 999men Hypertension 1998 31 3 780 786 (Pubitemid 28108576)
5. Forette F., Seux M. L., Staessen J. A., Thijs L., Birkenhger W. H., Babarskiene M. R., Babeanu S., Bossini A., Gil-Extremera B., Girerd X., Laks T., Lilov E., Moisseyev V., Tuomilehto J., Vanhanen H., Webster J., Yodfat Y., Fagard R., Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial The Lancet 1998 352 9137 1347 1351 (Pubitemid 28510916)
6. Grant W. B., Dietary links to Alzheimer's disease: 1999 update Journal of Alzheimer's Disease 1999 1 4-5 197 201
7. Pyrl M., Miettinen H., Halonen P., Laakso M., Pyrl K., Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 2 538 544 (Pubitemid 30086114)
8. Meyer J. S., Rauch G. M., Rauch R. A., Haque A., Crawford K., Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia Annals of the New York Academy of Sciences 2000 903 411 423 (Pubitemid 30251583)
9. Petot G. J., Traore F., Debanne S. M., Lerner A. J., Smyth K. A., Friedland R. P., Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life Metabolism 2003 52 3 279 281 (Pubitemid 36401671)
10. Gasparini L., Gouras G. K., Wang R., Gross R. S., Beal M. F., Greengard P., Xu H., Stimulation of -amyloid precursor protein trafficking by insulin reduces intraneuronal -amyloid and requires mitogen-activated protein kinase signaling Journal of Neuroscience 2001 21 8 2561 2570 (Pubitemid 32298198)
11. Miller B. C., Eckman E. A., Sambamurti K., Dobbs N., Martin Chow K., Eckman C. B., Hersh L. B., Thiele D. L., Amyloid- peptide levels in brain are inversely correlated with insulysin activity levels in vivo Proceedings of the National Academy of Sciences of the United States of America 2003 100 10 6221 6226 (Pubitemid 36576957)
12. Cook D. G., Leverenz J. B., McMillan P. J., Kulstad J. J., Ericksen S., Roth R. A., Schellenberg G. D., Jin L. W., Kovacina K. S., Craft S., Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E- 4 allele American Journal of Pathology 2003 162 1 313 319 (Pubitemid 36042013)
13. Phiel C. J., Wilson C. A., Lee V. M. Y., Klein P. S., GSK-3 regulates production of Alzheimer's disease amyloid- peptides Nature 2003 423 6938 435 439 (Pubitemid 36626994)
14. Ho L., Qin W., Pompl P. N., Xiang Z., Wang J., Zhao Z., Peng Y., Cambareri G., Rocher A., Mobbs C. V., Hof P. R., Pasinetti G. M., Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease The FASEB journal 2004 18 7 902 904
15. Cao D., Lu H., Lewis T. L., Li N., Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease Journal of Biological Chemistry 2007 282 50 36275 36282
16. Li L., Hlscher C., Common pathological processes in Alzheimer disease and type 2 diabetes: a review Brain Research Reviews 2007 56 2 384 402 (Pubitemid 350166529)
17. Craft S., Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment Current Alzheimer Research 2007 4 2 147 152 (Pubitemid 46557503)
18. Liu Y., Liu F., Grundke-Iqbal I., Iqbal K., Gong C.-X., Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes Journal of Pathology 2011 225 1 54 62
19. Steen E., Terry B. M., Rivera E. J., Cannon J. L., Neely T. R., Tavares R., Xu X. J., Wands J. R., De La Monte S. M., Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's diseaseis this type 3 diabetes? Journal of Alzheimer's Disease 2005 7 1 63 80 (Pubitemid 40387185)
20. Taniguchi C. M., Emanuelli B., Kahn C. R., Critical nodes in signalling pathways: insights into insulin action Nature Reviews Molecular Cell Biology 2006 7 2 85 96 (Pubitemid 43278292)
21. Frlich L., Blum-Degen D., Bernstein H. G., Engelsberger S., Humrich J., Laufer S., Muschner D., Thalheimer A., Trk A., Hoyer S., Zchling R., Boissl K. W., Jellinger K., Riederer P., Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease Journal of Neural Transmission 1998 105 4-5 423 438 (Pubitemid 28365027)
22. Rivera E. J., Goldin A., Fulmer N., Tavares R., Wands J. R., De La Monte S. M., Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine Journal of Alzheimer's Disease 2005 8 3 247 268
23. Moloney A. M., Griffin R. J., Timmons S., O'Connor R., Ravid R., O'Neill C., Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling Neurobiology of Aging 2010 31 2 224 243
24. Baum L., Hansen L., Masliah E., Saitoh T., Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation Molecular and Chemical Neuropathology 1996 29 2-3 253 261 (Pubitemid 27016933)
25. Griffin R. J., Moloney A., Kelliher M., Johnston J. A., Ravid R., Dockery P., O'Connor R., O'Neill C., Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology Journal of Neurochemistry 2005 93 1 105 117 (Pubitemid 40463520)
26. Balaraman Y., Limaye A. R., Levey A. I., Srinivasan S., Glycogen synthase kinase 3 and Alzheimer's disease: pathophysiological and therapeutic significance Cellular and Molecular Life Sciences 2006 63 11 1226 1235 (Pubitemid 43939009)
27. Leroy K., Yilmaz Z., Brion J. P., Increased level of active GSK-3 in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration Neuropathology and Applied Neurobiology 2007 33 1 43 55 (Pubitemid 46090309)
28. Sugden P. H., Fuller S. J., Weiss S. C., Clerk A., Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis British Journal of Pharmacology 2008 153 supplement 1 S137 S153
29. Hooper C., Killick R., Lovestone S., The GSK3 hypothesis of Alzheimer's disease Journal of Neurochemistry 2008 104 6 1433 1439 (Pubitemid 351316776)
30. Rosen O. M., After insulin binds Science 1987 237 4821 1452 1458 (Pubitemid 17125440)
31. Youngren J. F., Regulation of insulin receptor function Cellular and Molecular Life Sciences 2007 64 7-8 873 891 (Pubitemid 46597750)
32. Haroutunian V., Perl D. P., Purohit D. P., Marin D., Khan K., Lantz M., Davis K. L., Mohs R. C., Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease Archives of Neurology 1998 55 9 1185 1191 (Pubitemid 28427489)
33. Haroutunian V., Purohit D. P., Perl D. P., Marin D., Khan K., Lantz M., Davis K. L., Mohs R. C., Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease Archives of Neurology 1999 56 6 713 718 (Pubitemid 29266472)
34. Morris J. C., The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 1993 43 11 2412 2414 (Pubitemid 23346995)
35. Beeri M. S., Silverman J. M., Davis K. L., Marin D., Grossman H. Z., Schmeidler J., Purohit D. P., Perl D. P., Davidson M., Mohs R. C., Haroutunian V., Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology Journals of Gerontology A 2005 60 4 471 475 (Pubitemid 40712864)
36. Beeri M. S., Schmeidler J., Silverman J. M., Gandy S., Wysocki M., Hannigan C. M., Purohit D. P., Lesser G., Grossman H. T., Haroutunian V., Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology Neurology 2008 71 10 750 757
37. Mirra S. S., The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary Neurobiology of Aging 1997 18 4, supplement 1 S91 S94
38. Yamamoto T., Hirano A., A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles Neuropathology and Applied Neurobiology 1986 12 1 3 9 (Pubitemid 16168220)
39. Nslund J., Haroutunian V., Mohs R., Davis K. L., Davies P., Greengard P., Buxbaum J. D., Correlation between elevated levels of amyloid -peptide in the brain and cognitive decline Journal of the American Medical Association 2000 283 12 1571 1577 (Pubitemid 30161512)
40. Li J., Gould T. D., Yuan P., Manji H. K., Chen G., Post-mortem interval effects on the phosphorylation of signaling proteins Neuropsychopharmacology 2003 28 6 1017 1025
41. De La Monte S. M., Tong M., Lester-Coll N., Plater M., Wands J. R., Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease Journal of Alzheimer's Disease 2006 10 1 89 109 (Pubitemid 44401370)
42. White M. F., Regulating insulin signaling and -cell function through IRS proteins Canadian Journal of Physiology and Pharmacology 2006 84 7 725 737 (Pubitemid 44897893)
43. van der Heide L. P., Ramakers G. M. J., Smidt M. P., Insulin signaling in the central nervous system: learning to survive Progress in Neurobiology 2006 79 4 205 221 (Pubitemid 44331498)
44. Chakraborty C., Biochemical and molecular basis of insulin resistance Current Protein and Peptide Science 2006 7 2 113 121
45. Whiteman E. L., Cho H., Birnbaum M. J., Role of Akt/protein kinase B in metabolism Trends in Endocrinology and Metabolism 2002 13 10 444 451 (Pubitemid 36733939)
46. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., Kondo T., Alber J., Galldiks N., Kstermann E., Arndt S., Jacobs A. H., Krone W., Ronald Kahn C., Brning J. C., Role for neuronal insulin resistance in neurodegenerative diseases Proceedings of the National Academy of Sciences of the United States of America 2004 101 9 3100 3105 (Pubitemid 38327741)
47. Longnus S. L., Ségalen C., Giudicelli J., Sajan M. P., Farese R. V., Van Obberghen E., Insulin signalling downstream of protein kinase B is potentiated by 5′AMP-activated protein kinase in rat hearts in vivo Diabetologia 2005 48 12 2591 2601 (Pubitemid 41738227)
48. Garcia-Segura L. M., Sanz A., Mendez P., Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection Neuroendocrinology 2007 84 4 275 279 (Pubitemid 46391718)
49. King T. D., Song L., Jope R. S., AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3 Biochemical Pharmacology 2006 71 11 1637 1647
50. Rayasam G. V., Tulasi V. K., Sodhi R., Davis J. A., Ray A., Glycogen synthase kinase 3: more than a namesake British Journal of Pharmacology 2009 156 6 885 898
51. Schiaffino S., Mammucari C., Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models Skeletal Muscle 2011 1 1, article 4
52. Tsakiridis T., Tsiani E., Lekas P., Bergman A., Cherepanov V., Whiteside C., Downey G. P., Insulin, insulin-like growth factor-1, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells Biochemical and Biophysical Research Communications 2001 288 1 205 211 (Pubitemid 32999747)
53. Takashima A., GSK-3 is essential in the pathogenesis of Alzheimer's disease Journal of Alzheimer's Disease 2006 9 3 309 317 (Pubitemid 44253325)
54. Erol A., Unraveling the molecular mechanisms behind the metabolic basis of sporadic alzheimer's disease Journal of Alzheimer's Disease 2009 17 2 267 276
55. Reger M. A., Watson G. S., Green P. S., Wilkinson C. W., Baker L. D., Cholerton B., Fishel M. A., Plymate S. R., Breitner J. C.S., DeGroodt W., Mehta P., Craft S., Intranasal insulin improves cognition and modulates -amyloid in early AD Neurology 2008 70 6 440 448
56. Benedict C., Hallschmid M., Hatke A., Schultes B., Fehm H. L., Born J., Kern W., Intranasal insulin improves memory in humans Psychoneuroendocrinology 2004 29 10 1326 1334 (Pubitemid 39024358)
57. Reger M. A., Watson G. S., Frey W. H., Baker L. D., Cholerton B., Keeling M. L., Belongia D. A., Fishel M. A., Plymate S. R., Schellenberg G. D., Cherrier M. M., Craft S., Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype Neurobiology of Aging 2006 27 3 451 458 (Pubitemid 43185331)
58. Landreth G., Therapeutic use of agonists of the nuclear receptor PPAR in Alzheimer's disease Current Alzheimer Research 2007 4 2 159 164 (Pubitemid 46557505)
59. Hll M., Berger M., Heneka M., Disease-modifying therapies in Alzheimer's disease: how far have we come? Drugs 2006 66 16 2075 2093 (Pubitemid 46372359)